The levels of VEGF-C in the sera of 109 ovarian cancer patients were assessed in relation to clinicopathological features of tumor such as FIGO stage, grading, tumor location, lymph node metastasis, tumor resectability, and survival of the patients. Here, VEGFC is linked to metastatic malignant neoplasm in the lymph nodes.